Featured in Newsweek, Vella Bioscience CEO Carolyn Wheeler discusses reshaping the conversation around women’s sexual wellness, pleasure, and health access through science-backed innovation and better education. The article highlights Vella Bioscience’s mission to close longstanding gaps in women’s health by creating products designed specifically for female arousal, hormonal wellness, and intimate care. Wheeler emphasizes the importance of language, awareness, and research in helping women better understand their bodies and access effective solutions.
The feature also explores Vella Bioscience’s commitment to clinically driven product development and broader advocacy for women’s health. As a valued CAT partner, Vella reflects the growing demand for brands that prioritize wellness, empowerment, and evidence-based solutions for women at every life stage. Their continued recognition in national media reinforces the importance of innovation, access, and open conversations surrounding female health and wellbeing.
